Revolution Medicines Inc (RVMD)
40.20
+1.01
(+2.58%)
USD |
NASDAQ |
May 03, 16:00
40.20
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines Shareholders Equity (Quarterly): 1.826B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.826B |
| September 30, 2023 | 837.46M |
| June 30, 2023 | 930.84M |
| March 31, 2023 | 952.22M |
| December 31, 2022 | 685.19M |
| September 30, 2022 | 681.42M |
| June 30, 2022 | 498.84M |
| March 31, 2022 | 550.99M |
| December 31, 2021 | 602.57M |
| September 30, 2021 | 638.20M |
| Date | Value |
|---|---|
| June 30, 2021 | 685.01M |
| March 31, 2021 | 722.58M |
| December 31, 2020 | 474.68M |
| September 30, 2020 | 505.07M |
| June 30, 2020 | 360.50M |
| March 31, 2020 | 385.32M |
| December 31, 2019 | 152.54M |
| September 30, 2019 | 165.67M |
| December 31, 2018 | 96.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
152.54M
Minimum
Dec 2019
1.826B
Maximum
Dec 2023
647.51M
Average
620.39M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cutera Inc | -159.83M |
| BioSig Technologies Inc | -2.913M |
| TRACON Pharmaceuticals Inc | -0.809M |
| Zentalis Pharmaceuticals Inc | 437.28M |
| Day One Biopharmaceuticals Inc | 346.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.062B |
| Total Liabilities (Quarterly) | 235.51M |
| Current Ratio | 13.06 |